Wellcome is changing who can apply for its grants, in two stages. From 1 July 2026, new eligibility rules take effect for new applications to several schemes, including the Discovery Awards and Career Development Awards, alongside separate transitional rules for resubmissions. Then, from 29 October 2026, Wellcome will only accept applications from lead applicants based at eligible administering organisations in the UK and in low- and middle-income countries (LMICs) in Africa, South Asia, and South-East Asia — a narrower geographic footprint than the LMIC eligibility most schemes have used previously. Both changes are set out on Wellcome’s own eligibility information for grant applicants page. Research offices supporting applicants to Wellcome funding, especially those outside the UK, should treat both dates as operationally significant.
What changes on 1 July 2026
Wellcome’s guidance states that new eligibility criteria apply to new applications submitted on or after 1 July 2026, with resubmissions of applications made before that date continuing to follow the rules that were in place when they were first submitted. The detail is scheme-specific. For the Wellcome Career Development Award, Wellcome’s published transition guidance gives applicants whose three years in a permanent post falls between 28 July 2026 and 17 November 2026 a window to apply up to and including 17 November 2026, rather than being cut off mid-cycle by the new rule. For the Discovery Awards, the revised criteria apply straightforwardly to new applications from 1 July 2026 onward. Because the exact eligibility windows and grandfathering provisions differ by scheme, research administrators should check the live scheme page for any award their institution is preparing an application for rather than assuming a single rule applies across all of Wellcome’s funding lines.
What changes on 29 October 2026: host-institution eligibility narrows
The more consequential change for institutions outside the UK lands on 29 October 2026. From that date, Wellcome states it will only accept applications from lead applicants based at eligible administering organisations in the UK and in low- and middle-income countries in three specific regions: Africa, South Asia, and South-East Asia. This is a real narrowing relative to the broader, more globally distributed LMIC eligibility that Wellcome’s major schemes — including Discovery Awards, Early-Career Awards, and Career Development Awards — have used up to that point. Administering organisations in LMICs outside those three regions (for example, in Latin America, the Caribbean, Eastern Europe, or the Pacific) will no longer qualify as a lead applicant’s host institution under the new rule, even where they were eligible previously.
Resubmissions are treated as a distinct case: Wellcome’s guidance indicates that resubmissions of applications originally submitted before 29 October 2026 will continue to follow the previous resubmission rules, rather than being pulled forward into the new geographic restriction immediately. As with the July change, institutions should confirm the exact resubmission treatment against the specific scheme’s current guidance, since Wellcome’s schemes are not all on identical cycles.
Why the host-institution restriction matters
Wellcome funds a substantial share of global health and biomedical research outside the UK precisely through its LMIC eligibility provisions, and many institutions have built research partnerships and career pathways around being an eligible host. A geographic narrowing to Africa, South Asia, and South-East Asia changes the calculus for institutions in other LMIC regions in at least three concrete ways for a research office to plan around:
- Lead-applicant status. An institution that could previously serve as the administering organisation for a Wellcome lead applicant may need to restructure a planned application so the lead applicant is based at an eligible partner institution instead, with the newly-ineligible institution participating as a collaborator or co-investigator site rather than the host.
- Timing of submission. Applications intended for an institution that will fall outside the new eligibility footprint need to be submitted, and ideally have outline or preliminary stages cleared, before 29 October 2026 wherever a scheme’s process allows it — research offices should map their internal deadlines against Wellcome’s external ones now rather than close to the date.
- Consortium and subaward planning. Where a project already involves multiple institutions, research offices should revisit which partner is administratively best positioned to be the eligible host under the new rule, since that decision affects who signs Wellcome’s grant conditions and manages the award.
What research offices should do now
- Identify any Wellcome applications currently in preparation, or planned for late 2026, where the lead applicant’s host institution is outside the UK and outside Africa, South Asia, and South-East Asia, and flag them for review against the 29 October 2026 cutoff.
- Check the specific scheme page (Discovery Awards, Career Development Awards, Early-Career Awards, and others) for the exact eligibility wording and any transitional windows, since Wellcome has published scheme-specific detail rather than a single uniform rule.
- For applicants whose eligibility for a scheme (such as years since a permanent post began, for Career Development Awards) sits close to a scheme’s stated transition window, confirm which side of the window they fall on well before the submission deadline.
- Where a resubmission is planned, confirm with Wellcome or the relevant programme team which rule set — pre- or post-change — applies to that specific resubmission.
Frequently asked questions
Does the 29 October 2026 change affect co-investigators, or only the lead applicant’s host institution?
Wellcome’s published change is specifically about the eligibility of the lead applicant’s administering organisation. Research offices should still check individual scheme guidance for how co-investigator or partner-site eligibility is treated, since that is a separate question from where the lead applicant is based.
Does this apply to every Wellcome funding scheme?
The geographic narrowing to the UK plus Africa, South Asia, and South-East Asia is described by Wellcome as applying across its major schemes, including Discovery Awards, Early-Career Awards, and Career Development Awards. Always confirm against the specific scheme page, since Wellcome funds a range of other mechanisms (including partnership and translational funding) that may have their own eligibility terms.
What happens to an application already submitted before the changes take effect?
Wellcome’s guidance draws a distinction between new applications and resubmissions: resubmissions of applications originally submitted before 29 October 2026 are stated to continue under the previous resubmission rules, rather than being subject to the new host-institution restriction immediately. Confirm the specific treatment with the relevant programme team if a resubmission is in progress.
Where can research offices find the authoritative, current version of these rules?
Wellcome maintains eligibility information directly on its own site, under Eligibility Information for Organisations, and on each individual scheme’s page. Because eligibility rules are funder-set and can be revised, that page — not a secondary summary — is the source to check before finalising an application strategy.
For background on how Wellcome’s funding portfolio is organised, see CASRAI’s guide to Wellcome Trust funding, which covers how the Discovery Awards, Career Development Awards, and Early-Career Awards fit together as a career pathway.
